Menu visibility control

Video

Events

Startup Surgery

Most Recent

Government & Policy

PM Theresa May to reveal Industrial Strategy Challenge Fund to support UK tech

Tech City Voices

Here’s how tech for good startups can maximise their chances of getting funded

Investments

Habito lands £5.5m in Series A round led by Silicon Valley’s Ribbit Capital

Press Releases

No more electronic ‘loose change’: innovative fintech charity payment scheme launched today across 6,000 UK schools
Chimni calls for the UK proptech community to work more closely with the housebuilding industry
Blockchain Conference: Blockchain Expo announces Berlin and North America dates

Cambridge-based Healx secures £1.5m Series A to combat rare diseases

medication
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

HealthTech startup Healx has secured a £1.5m Series A round from Amadeus Capital and Jonathan Milner, a healthcare entrepreneur.

The Cambridge-based firm, which uses machine learning and advanced data analytics, seeks to find new uses for existing drugs in an attempt to combat rare diseases.

Hermann Hauser, partner and co-founder of Amadeus Capital Partners, said: “Healx has taken advances in machine learning, data mining and analytics and combined them with deep pharma and life sciences expertise to address a growing need in the healthcare sector.

October funding roundup: UK tech investment tops £130m

“With huge pressure on R&D budgets, drug repositioning will be essential in the fight against rare diseases,” he added.

Healx’s technology platform matches potential treatments to rare conditions and patients. The company aims to complete its drug repurposing studies within six months.

Tim Guilliams, founder & CEO at Healx, commented: “Studies into rare medical conditions have long failed to receive adequate funding.”

The firm says it will use the money to expand its technology platform and accelerate the drug review process, in hope to find treatments to more illnesses.

“By repurposing existing drugs to combat rare diseases, Healx is able to find potential treatments at a fraction of the cost and in a much shorter timeframe than developing a new drug,” Guilliams concluded.

Enter your e-mail address to receive updates straight to your inbox

* indicates required
Send me news on...
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Editor's picks

Theresa May

PM Theresa May to reveal Industrial Strategy Challenge Fund to support UK tech
posted 2 hours ago

Tech for good

Here’s how tech for good startups can maximise their chances of getting funded
posted 6 hours ago

habito

Habito lands £5.5m in Series A round led by Silicon Valley’s Ribbit Capital
posted 13 hours ago

BULB Amit Gudka

Amit Gudka, co-founder of Bulb, on the biggest misconceptions of startup life and his proudest moment so far
posted on January 22, 2017

Reports

Top tech stats: HealthTech investments trends, AI within business & more
posted on January 21, 2017

legal robot

AI and the legal sector: Opportunities, challenges and predictions
posted on January 20, 2017